PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Heart failure (HF) has a significant impact on patient outcomes and health care costs. Objective monitoring of pitting edema level of a HF patient may help clinicians reduce the volume of patient re-admissions. To address this, ChemImage is developing a Molecular Chemical Imaging (MCI) device for noninvasive measurement of peripheral edema level in HF patients. In an initial clinical study, edema grade was predicted in HF patients with 86% accuracy. Results from a follow-up clinical trial demonstrating the capability of MCI to monitor changes in a HF patient’s peripheral edema over time during the course of treatment will be presented.
Aaron Smith,Shona D. Stewart,Marlena Darr,Arash Samiei,Robert Schweitzer,Matthew Nelson,Patrick Treado,Jeffrey Cohen, andJames C. Post
"Monitoring peripheral edema in heart failure patients and a normal cohort using molecular chemical imaging (MCI)", Proc. SPIE 11638, Biophotonics in Exercise Science, Sports Medicine, Health Monitoring Technologies, and Wearables II, 1163809 (5 March 2021); https://doi.org/10.1117/12.2577989
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Aaron Smith, Shona D. Stewart, Marlena Darr, Arash Samiei, Robert Schweitzer, Matthew Nelson, Patrick Treado, Jeffrey Cohen, James C. Post, "Monitoring peripheral edema in heart failure patients and a normal cohort using molecular chemical imaging (MCI)," Proc. SPIE 11638, Biophotonics in Exercise Science, Sports Medicine, Health Monitoring Technologies, and Wearables II, 1163809 (5 March 2021); https://doi.org/10.1117/12.2577989